Clinical genome sequencing and population preferences for information about ‘incidental’ findings—From medically actionable genes (MAGs) to patient actionable genes (PAGs)-Reference-Cited by-同舟云学术

Clinical genome sequencing and population preferences for information about ‘incidental’ findings—From medically actionable genes (MAGs) to patient actionable genes (PAGs)

Published:2017-07-03 Issue:7 Volume:12 Page:e0179935
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ploug Thomas,Holm Søren

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference52 articles.

1. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing;Genet Med,2013

2. Incidental findings in clinical genomics: a clarification;Genet Med,2013

3. Patient Autonomy and Incidental Findings in Clinical Genomics;SM Wolf;Science,2013

4. Looking for Trouble: Preventive Genomic Sequencing in the General Population and the Role of Patient Choice;G Lázaro-Muñoz;Am J Bioeth,2015

5. Ethics and Genomic Incidental Findings;AL McGuire;Science,2013

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The value of knowing: preferences for genetic testing to diagnose rare muscle diseases;Orphanet Journal of Rare Diseases;2024-04-22

2. Duty to recontact in genomic cancer care: A tool helping to assess the professional’s responsibility;European Journal of Cancer;2023-06

3. Great expectations: patients’ preferences for clinically significant results from genomic sequencing;Human Genetics;2023-03-21

4. Organoid biobanking, autonomy and the limits of consent;Bioethics;2022-05-09

5. Public interest in unexpected genomic findings: a survey study identifying aspects of sequencing attitudes that influence preferences;Journal of Community Genetics;2022-01-21